Diabetes Kongress 2022
Kalender Liste Personen Favoriten
zur Liste
Dr. Sebastian Pieperhoff
Novo Nordisk Pharma GmbH Germany
  • Vortrag Once-Weekly Semaglutide 1 mg vs Empagliflozin 25 mg as Add-On to Metformin Monotherapy in Patients with Type 2 Diabetes: a Meta-Regression Analysis of Individual Patient Data Speaker
    Datum: 26.05.2022 , Zeit: 14:14 | Thema: Poster
    Details
  • Vortrag Real-world use of once-weekly semaglutide in type 2 diabetes: results from SURE Germany Autor:in
    Datum: 27.05.2022 , Zeit: 11:47 | Thema: Poster
    Details